Cusatuzumab (Anti-TNFSF7 / CD27L / CD70)
A2747
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameCusatuzumab (Anti-TNFSF7 / CD27L / CD70)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionCusatuzumab (Anti-TNFSF7 / CD27L / CD70) is a defucosylated, humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML). MW: 144.36 kD.
- Storage Instruction-20°C
- UNSPSC12352203